Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
13976
Outset Medical
OM
$77.1M
| $3.24K | ﹤0.01% |
195
| – | – |
2020 Q3
17 quarters
|
|
|
AITRR
13977
DELISTED
AI Transportation Acquisition Corp Right
AITRR
| $3.23K | ﹤0.01% |
24,882
-19,616
| -44% | -$2.5K |
2024 Q1
3 quarters
|
|
|
XAGEW
13978
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
| $3.22K | ﹤0.01% |
46,836
-28,538
| -38% | -$1.67K |
2024 Q1
3 quarters
|
|
13979
PUT
IHS Holding
IHS
$2.86B
| $3.21K | ﹤0.01% |
1,100
-1,800
| -62% | -$5.46K |
2022 Q3
9 quarters
|
|
|
BPT
13980
CALL
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $3.21K | ﹤0.01% |
5,900
-23,400
| -80% | -$23.6K |
2024 Q3
1 quarter
|
|
13981
PUT
Accel Entertainment
ACEL
$896M
| $3.2K | ﹤0.01% |
300
-3,500
| -92% | -$40K |
2022 Q4
8 quarters
|
|
13982
CALL
Nuvation Bio
NUVB
$1.74B
| $3.19K | ﹤0.01% |
1,200
-2,000
| -63% | -$5.15K |
2022 Q4
8 quarters
|
|
13983
CALL
Invesco MSCI Global Timber ETF
CUT
$29M
| $3.17K | ﹤0.01% |
100
-1,000
| -91% | -$34.1K |
2024 Q3
1 quarter
|
|
|
13984
PUT
Invesco MSCI Global Timber ETF
CUT
$29M
| $3.17K | ﹤0.01% |
100
-200
| -67% | -$6.82K |
2024 Q3
1 quarter
|
|
|
IMMP
13985
Immutep
IMMP
$31.1M
| $3.15K | ﹤0.01% |
73
-911
| -93% | -$36.6K |
2024 Q1
3 quarters
|
|
13986
CALL
SOPHiA GENETICS
SOPH
$704M
| $3.12K | ﹤0.01% |
1,000
-4,900
| -83% | -$16.7K |
2024 Q3
1 quarter
|
|
13987
CALL
Taysha Gene Therapies
TSHA
$1.43B
| $3.11K | ﹤0.01% |
1,800
-8,600
| -83% | -$17.8K |
2022 Q1
11 quarters
|
|
13988
PUT
Xperi
XPER
$263M
| $3.08K | ﹤0.01% |
300
-3,800
| -93% | -$35.5K |
2022 Q4
8 quarters
|
|
|
CUTR
13989
CALL
DELISTED
Cutera, Inc.
CUTR
| $3.07K | ﹤0.01% |
8,700
-63,100
| -88% | -$31.4K |
2021 Q1
15 quarters
|
|
|
CLLS
13990
PUT
Cellectis
CLLS
$139M
| $3.06K | ﹤0.01% |
1,700
+300
| +21% | +$560 |
2024 Q2
2 quarters
|
|
|
CFB
13991
CALL
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $3.03K | ﹤0.01% |
200
-900
| -82% | -$14.9K |
2024 Q3
1 quarter
|
|
13992
CALL
Five Star Bancorp
FSBC
$1.07B
| $3.01K | ﹤0.01% |
+100
| New | +$3.13K |
2024 Q4
0 quarters
|
|
13993
PUT
MarketWise
MKTW
$55.8M
| $3.01K | ﹤0.01% |
265
-495
| -65% | -$5.53K |
2023 Q4
4 quarters
|
|
13994
PUT
Flux Power
FLUX
$11.4M
| $3K | ﹤0.01% |
1,900
+1,000
| +111% | +$2.37K |
2024 Q1
3 quarters
|
|
13995
CALL
WisdomTree Trust WisdomTree China ex-State-Owned Enterprises Fund
CXSE
$452M
| $2.99K | ﹤0.01% |
+100
| New | +$3.2K |
2024 Q4
0 quarters
|
|
|
ATMCR
13996
DELISTED
AlphaTime Acquisition Corp Right
ATMCR
| $2.98K | ﹤0.01% |
22,054
-1,819
| -8% | -$344 |
2023 Q2
6 quarters
|
|
13997
CALL
iShares 25+ Year Treasury STRIPS Bond ETF
GOVZ
$309M
| $2.96K | ﹤0.01% |
75
-325
| -81% | -$14K |
2024 Q1
3 quarters
|
|
13998
CALL
Werewolf Therapeutics
HOWL
$45.3M
| $2.96K | ﹤0.01% |
2,000
+1,300
| +186% | +$2.65K |
2023 Q4
4 quarters
|
|
|
SERV
13999
Serve Robotics
SERV
$414M
| $2.96K | ﹤0.01% |
+219
| New | +$2.3K |
2024 Q4
0 quarters
|
|
14000
CALL
Farmers & Merchants Bancorp
FMAO
$487M
| $2.94K | ﹤0.01% |
100
-2,500
| -96% | -$74.7K |
2024 Q2
2 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.